Ganesan Vaidyanathan, Professor in Radiology

Office Location:  161C Bryan Res Building
Office Phone:  (919) 684-7811
Email Address: send me a message
Web Page:  http://faculty.duhs.duke.edu/faculty/info?pid=1994

Education:

Ph.D.University of Kentucky at Lexington1987
Representative Publications

  1. Vaidyanathan G, Zalutsky MR. Preparation of 5-[131I]Iodo-([131I]FIAU) and 5-[211At]Astato-1(2-deoxy-2fluro-B-D-arabinoffuranosyl)uracil ([211AT]FAAU) by a halodestannylation reaction. Nucl Med Biol 1998, 25:487-496.
  2. Vaidyanathan G, Affleck DJ, Zalutsky MR. A method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4[131I] iodobenzoate. Bioconjugate Chem. 1997, 8:724-129.
  3. Vaidyanathan G, Larsen RH, Zalutsky MR. 5[211at]Astato-2'-deoxyuridine, an a-particle emitting endoradiotherapeutic agent undergoing DNA incorporation. Cancer Res., 1996, 56, 1204-1209.
  4. Vaidyanathan, G., Larsen, R.H. and Zalutsky, M.R. 5[211At]Astato-2'-deoxyuridine, an à-particle emitting endoradiotherapeutic agent undergoing DNA incorporation. Cancer Res., 1996, 56, 1204-1209.
  5. Vaidyanathan, G. Affleck DJ, Zalutsky MR. Validation of 4-[18F] Fluoro-3-iodobenzylguanidine as a potential PET analog of MIBG. J Nucl Med 1995, 36:644-650.
  6. Vaidyanathan, G. and Zalutsky, M.R. Fluorine-18 labeled chemotactic peptides: A potential approach for the PET imaging of bacterial infections. Nucl.Med. Biol. 1995, 22:759-764.
  7. Vaidyanathan, G., Affleck, D.J. and Zalutsky, M.R. Validation of 4-[18F]Fluoro-3-iodobenzylguanidine as a potential PET analog of MIBG. J. Nucl. Med. 1995, 36: 644-650.
  8. Strickland, D.K., Vaidyanathan, G. and Zalutsky, M.R. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells. Cancer Res. 1994, 54, 5414-5419.
  9. Vaidyanathan, G., Bigner, D.D. and Zalutsky, M.R. Fluorine-18 labeled monoclonal antibody fragments: A potential approach for combining radioimmunotherapy and positron emission tomography. J. Nucl. Med. 33: 1535-1541, 1992.